393 related articles for article (PubMed ID: 16226752)
1. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
2. Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):870-3. PubMed ID: 16182296
[TBL] [Abstract][Full Text] [Related]
3. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
Lindmark T; Nikkilä T; Artursson P
J Pharmacol Exp Ther; 1995 Nov; 275(2):958-64. PubMed ID: 7473188
[TBL] [Abstract][Full Text] [Related]
5. Effect of bile salts and fatty acids on the colonic absorption of oxalate.
Dobbins JW; Binder HJ
Gastroenterology; 1976 Jun; 70(6):1096-1100. PubMed ID: 1269869
[TBL] [Abstract][Full Text] [Related]
6. Effects of amphotericin B and cholera toxin on intestinal transport in the rat. An in vivo model for the effects of dihydroxy bile acids and fatty acids on intestinal transport.
Ammon HV; Walter LG; Loeffler RF
J Lab Clin Med; 1983 Oct; 102(4):509-21. PubMed ID: 6413628
[TBL] [Abstract][Full Text] [Related]
7. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
8. Bile salt-enhanced rat jejunal absorption of a macromolecular tracer.
Fagundes-Neto U; Teichberg S; Bayne MA; Morton B; Lifshitz F
Lab Invest; 1981 Jan; 44(1):18-26. PubMed ID: 7453128
[TBL] [Abstract][Full Text] [Related]
9. Bile salt regulation of fatty acid absorption and esterification in rat everted jejunal sacs in vitro and into thoracic duct lymph in vivo.
Clark ML; Lanz HC; Senior JR
J Clin Invest; 1969 Sep; 48(9):1587-99. PubMed ID: 5822571
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
11. [Biologic membrane functions in health and disease. Effects of bile acids and laxatives on the mucosal transfer].
Rummel W
Bull Schweiz Akad Med Wiss; 1976 Dec; 32(4-6):233-50. PubMed ID: 1009264
[TBL] [Abstract][Full Text] [Related]
12. Role of bile in pathogenesis of indomethacin-induced enteropathy.
Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
[TBL] [Abstract][Full Text] [Related]
13. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
Tomimatsu T; Horie T
Chem Biol Interact; 2005 Aug; 155(3):129-39. PubMed ID: 15996645
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.
Shao Z; Li Y; Chermak T; Mitra AK
Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
Maher S; Leonard TW; Jacobsen J; Brayden DJ
Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
[TBL] [Abstract][Full Text] [Related]
16. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
[TBL] [Abstract][Full Text] [Related]
17. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of intestinal absorption of 2-methyl cytidine prodrugs.
Cianetti S; Cooper VB; Attenni B; Pucci V; Fiore F; Giuliano C; Laufer R; Gardelli C; Monteagudo E; Narjes F; Pearce GE; Rowley M
Drug Deliv; 2010 May; 17(4):214-22. PubMed ID: 20233089
[TBL] [Abstract][Full Text] [Related]
19. [Study on pulmonary delivery of peptide drugs in rats: effects of absorption enhancers on cellular membrane fluidity].
Wang ZY; Zhang Q
Yao Xue Xue Bao; 2003 Dec; 38(12):957-61. PubMed ID: 15040095
[TBL] [Abstract][Full Text] [Related]
20. Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP).
Lundin PD; Bojrup M; Ljusberg-Wahren H; Weström BR; Lundin S
J Pharmacol Exp Ther; 1997 Aug; 282(2):585-90. PubMed ID: 9262318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
